Correlation Between Histogen and Polarityte
Can any of the company-specific risk be diversified away by investing in both Histogen and Polarityte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Polarityte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Polarityte, you can compare the effects of market volatilities on Histogen and Polarityte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Polarityte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Polarityte.
Diversification Opportunities for Histogen and Polarityte
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Histogen and Polarityte is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Polarityte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polarityte and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Polarityte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polarityte has no effect on the direction of Histogen i.e., Histogen and Polarityte go up and down completely randomly.
Pair Corralation between Histogen and Polarityte
If you would invest 2.00 in Histogen on September 23, 2024 and sell it today you would earn a total of 0.77 from holding Histogen or generate 38.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 4.76% |
Values | Daily Returns |
Histogen vs. Polarityte
Performance |
Timeline |
Histogen |
Polarityte |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Histogen and Polarityte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Histogen and Polarityte
The main advantage of trading using opposite Histogen and Polarityte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Polarityte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polarityte will offset losses from the drop in Polarityte's long position.Histogen vs. Virax Biolabs Group | Histogen vs. Altamira Therapeutics | Histogen vs. Aileron Therapeutics | Histogen vs. Artelo Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world |